Researcher at INSERM research unit SESSTIM (Marseille). She specializes in the quantitative and qualitative social science approaches to investigate acceptability, expectations and preferences of people living with HIV. Her research interest includes eliciting barriers and motivations of HIV patients to participate in HIV cure-related clinical trials, ethical issues associated with HIV cure-related clinical trials and questions raised by chemsex practices.
Early ART initiation seems to favor post-treatment control of infection. However, only a minority of the individuals who are treated early is able to control viremia once the treatment is interrupted. Through retrospective analyses of data available in the ANRS CO6 PRIMO cohort and the Post-treatment controllers in the ANRS VISCONTI study, we have identified… Continue reading ANRS 175 RHIVIERA 01_Assessment of HIV remission upon ART interruption in early treated individuals from ANRS CO6 PRIMO cohort carrying the MHC genotype B35(53)Bw4TTC2
ART initiation during primary HIV infection limits the establishment, diversity and distribution of the viral reservoir while preserving key lymphoid organs of the deleterious effects of persistent viral replication and chronic immune activation, favoring the optimal maturation of immune responses. Early ART initiation may even facilitate long-term post-treatment control in some individuals. Therapeutic interventions during… Continue reading ANRS 176 RHIVIERA 02_Assessment of HIV remission upon ART interruption in individuals initiating ART in combination with two long lasting bNabs during primary infection
Protiere C, Fressard L, Mora M, Meyer L, Préau M, Suzan-Monti M, Lelièvre JD, Lambotte O, Spire B,
Vaccines (Basel). 2020 Jun 23;8(2):334.
Protiere C, Fiorentino M, Sow A, Préau M, Mora M, Fressard L, Meyer L, Lelièvre JD, Lambotte O, Spire B, Suzan-Monti M. AIDS. 2020 Jun 1;34(7):1095-1099. doi: 10.1097/QAD.0000000000002530. PMID: 32287066.
Protiere C, Arnold M, Fiorentino M, Fressard L, Lelièvre JD, Mimi M, Raffi F, Mora M, Meyer L, Sagaon-Teyssier L, Zucman D, Préau M, Lambotte O, Spire B, Suzan-Monti M
J Int AIDS Soc. 2020 Feb;23(2):e25443
Protière C, Préau M, Doumergue M, Mora M, Lambotte O, Spire B, Suzan-Monti M
HIV Clin Trials. 2017 Jul;18(4):174-175.
Protière C, Spire B, Mora M, Poizot-Martin I, Préau M, Doumergue M, Morlat P, Zucman D, Goujard C, Raffi F, Lambotte O, Suzan-Monti M.
PLoS One. 2017 Nov 2;12(11):e0187489.
